Article History
First Online: 7 May 2014
Competing interests
: K.H. has pending patents on ZFN-mediated genome editing in the liver and a patent on the use of AAV vectors to deliver clotting factor genes to the liver. P.D.G. is an employee of Sangamo Biosciences. C.G. is a consultant in the area of genome editing for several companies and an inventor on patent applications related to genome editing for the correction of genetic diseases.